Advertisement
Research Article
Source Data
Transparent Process
Open Access

Human IFITM3 restricts chikungunya virus and Mayaro virus infection and is susceptible to virus-mediated counteraction

Sergej Franz, Fabian Pott, Thomas Zillinger, Christiane Schüler, Sandra Dapa, Carlo Fischer, Vânia Passos, Saskia Stenzel, Fangfang Chen, Katinka Döhner, Gunther Hartmann, Beate Sodeik, Frank Pessler, Graham Simmons, Jan Felix Drexler, Christine Goffinet  Correspondence email
Published 2 June 2021. DOI: 10.26508/lsa.202000909

Article Information

vol. 4 no. 7 e202000909
DOI 
https://doi.org/10.26508/lsa.202000909
PubMed 
34078739
Published By 
Life Science Alliance
Online ISSN 
2575-1077
History 
  • Received September 16, 2020
  • Revision received May 21, 2021
  • Accepted May 21, 2021
  • Published online June 2, 2021.
Copyright & Usage 
© 2021 Franz et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).

Author Information

  1. Sergej Franz1,2,
  2. Fabian Pott3,4,
  3. Thomas Zillinger5,
  4. Christiane Schüler3,4,
  5. Sandra Dapa1,
  6. Carlo Fischer3,
  7. Vânia Passos1,
  8. Saskia Stenzel3,4,
  9. Fangfang Chen6,
  10. Katinka Döhner7,
  11. Gunther Hartmann3,
  12. Beate Sodeik7,8,
  13. Frank Pessler6,
  14. Graham Simmons2,
  15. Jan Felix Drexler3 and
  16. Christine Goffinet1,3,4⇑
  1. 1Institute of Experimental Virology, TWINCORE Centre for Experimental and Clinical Infection Research, a Joint Venture Between the Hannover Medical School (MHH) and the Helmholtz Centre for Infection Research (HZI), Hannover, Germany
  2. 2Vitalant Research Institute, San Francisco, CA, USA
  3. 3Charité–Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Virology, Berlin, Germany
  4. 4Berlin Institute of Health at Charité–Universitätsmedizin Berlin, Berlin, Germany
  5. 5Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, Venusberg-Campus 1, Bonn, Germany
  6. 6Research Group Biomarkers for Infectious Diseases, TWINCORE, Centre for Experimental and Clinical Infection Research, a Joint Venture Between the Hanover Medical School (MHH) and the Helmholtz Centre for Infection Research (HZI), Hanover, Germany
  7. 7Institute of Virology, Hannover Medical School, Hanover, Germany
  8. 8Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany
  1. Correspondence: christine.goffinet{at}charite.de
View Full Text

Funding

  • Deutsche Forschungsgemeinschaft (DFG), EXC 2155

    390874280, SFB 900–158989968 (TPC2)
    B Sodeik

  • DFG German/African Cooperation Projects in Infectiology

    GO2153/3-1
    C Goffinet

  • DFG

    GO2153/6-1
    C Goffinet

  • Impulse and Networking Fund of the Helmholtz Association

    PIE-008
    C Goffinet

  • Helmholtz Center for Infection Research (HZI), Berlin Institute of Health (BIH)

    C Goffinet
Back to top
Download PDF
Email Article
Citation Tools
Human IFITM3 restricts alphaviruses
Sergej Franz, Fabian Pott, Thomas Zillinger, Christiane Schüler, Sandra Dapa, Carlo Fischer, Vânia Passos, Saskia Stenzel, Fangfang Chen, Katinka Döhner, Gunther Hartmann, Beate Sodeik, Frank Pessler, Graham Simmons, Jan Felix Drexler, Christine Goffinet
Life Science Alliance Jun 2021, 4 (7) e202000909; DOI: 10.26508/lsa.202000909
Twitter logo Facebook logo Mendeley logo
Issue Cover

In this Issue

Volume 4, No. 7
July 2021
Advertisement

Jump to section

Subjects